Purchase Order HHSF223201510504A

This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Valley Biomedical Products and Services, Inc., a small disadvantaged business manufacturer, for the supply of human AB serum to support cellular therapy research programs at the NIH. The award, valued at $49,290.00, was made without full and open competition under simplified acquisition procedures. The serum will be used in various Phase I/II clinical trials at the NIH involving...

This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Solomon Park Research Laboratories, Inc., a veteran-owned biotechnology company, for $146,012.50. The contract is for the delivery of human blood serum and plasma products to support the CDC's disease testing and research efforts, including the development of laboratory standards. Solomon Park Research Laboratories has previous experience...

This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Solomon Park Research Laboratories, Inc., a for-profit, veteran-owned biotechnology company that specializes in providing human blood serum and plasma products. The $239,369.84 firm-fixed-price purchase order is for the delivery of C37 SERUM and will be performed in Seattle, WA. This contract supports the CDC's disease testing and research efforts, as Solomon...

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Life Technologies Corporation for $35,692.80. The contract calls for Life Technologies to deliver 80 units of heat inactivated fetal bovine serum with lot number 2661794P to the NIH Clinical Center in Bethesda, Maryland. The serum will support ongoing cell culture work and clinical research being performed by the Laboratory of Immunoregulation's HIV...

The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $12,925.85 firm-fixed-price purchase order to Biowest USA Inc., a for-profit organization, for the procurement of fetal bovine serum. The serum will be used to support a T-cell activation process study in normal and pathological states. This purchase order, which does not have a set-aside designation, has a performance period ending on December 9,...

The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...

This is a $146,960 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Solomon Park Research Laboratories, Inc., a veteran-owned biotechnology company specializing in human blood serum and plasma products. The contract is for the delivery of standardized serum products to support the CDC's disease testing and research efforts, including the development of laboratory standards. Solomon Park Research Laboratories has previously provided similar...

The U.S. Food and Drug Administration (FDA) awarded a $47,470.00 firm-fixed price purchase order contract to Stemexpress, LLC (doing business as CGT Global), a small disadvantaged woman-owned business, to provide human donor blood for the development of bioassays using peripheral blood mononuclear cells (PBMC) and/or isolated immune cells. The contract has an ultimate completion date of August 31, 2025 and does not utilize a set-aside. Stemexpress, a provider of human biological samples, has...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Labcorp Early Development Laboratories Inc., a for-profit contract research organization. The $19,430.00 contract is for canine plasma protein binding services, which involves analyzing the binding of drug compounds to proteins in animal plasma samples. This work supports NIH's mission of advancing...

This is a purchase order for 100 bottles of Hyclone-brand fetal bovine serum (US), each 500 mL, awarded by the National Center for Advancing Translational Sciences (part of the National Institutes of Health) to Government Scientific Source Inc. for $41,350.00 on a firm fixed price basis. The order has a completion date of February 28, 2018 and was not set aside for any specific business type. Government Scientific Source Inc. is a leading distributor of laboratory products and equipment that has...